- Iom Bioworks is harnessing the transformative potential of the gut microbiome to redefine modern healthcare.
- The newly secured funding will drive customer engagement, strengthen intellectual property protection, enhance infrastructure, and expand the scientific and commercial teams.
- In its first year, Iom Bioworks successfully reached 500 users, obtained two global patents (with two more in progress), and contributed to leading scientific publications in microbiome and computational biology research.
- Inflection Point Ventures has invested over INR 800 Cr, supporting more than 210 startups in their growth journeys.
Bengaluru, June 12, 2025 – Iom Bioworks, a deep science company pioneering microbiome-focused healthcare, has successfully raised ₹4 Cr in a Seed Round led by Inflection Point Ventures (IPV). The funding will be utilized to enhance marketing, strengthen core infrastructure, secure intellectual property, and scale both scientific and commercial teams.
Transforming Health Through Microbiome Science
Founded in 2022, Iom Bioworks focuses on personalized health solutions, identifying key gut bacteria and modulating them to improve digestion, immunity, metabolism, and overall well-being. Their patented platform integrates AI-driven knowledge graph mining and advanced modeling techniques, enabling precise, personalized health recommendations.
Proven Scientific Innovation & Market Presence
🔬 500+ customers reached within the first year
📜 Two patents granted, with two more in advanced stages
📚 Published in leading scientific journals
🚚 Pan-India logistics & digital access for microbiome services
Leadership Driving Scientific & Commercial Growth
🚀 Bipin Pradeep Kumar, Co-Founder & CEO – Strategic leadership blending microbiome research, AI, and customer-centric innovation
🔎 Dr. Samik Ghosh, Co-Founder & Chief of Science & Technology – Expertise in computational biology and microbiome-driven health solutions
🌍 Dr. Hiroaki Kitano, Co-Founder & Chief of Research & Collaboration – A globally recognized systems biologist and AI specialist, advancing robotics, scientific discovery, and innovative collaborations
Industry Perspectives on Gut Health Innovation
Vinay Bansal, Founder of IPV, emphasized the significance of microbiome science in addressing lifestyle diseases:
“The gut microbiome plays a crucial role in digestion, immunity, and even mood. Iom Bioworks is making this cutting-edge science accessible, personalized, and actionable, bridging the gap between innovation and practical health solutions.”
Bipin Pradeep Kumar, Co-Founder & CEO, reflected on the company’s vision:
“We aim to empower individuals through prebiotics, food, and lifestyle choices centered around the microbiome. Partnering with IPV has been transformative, setting us firmly on the path toward our vision of a healthier world through informed, microbiome-driven decisions.”
Positioned for Growth in the Expanding Wellness Market
With the global health testing and wellness market projected to reach USD 900 billion by 2030, growing at a CAGR of 28%, Iom Bioworks is well-positioned to lead the transition toward scalable, accessible gut health solutions, rooted in deep science and user-focused innovation.
Submitted by PR Agency
